Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shiho Miura

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Molecular Pharmaceutics|April 2, 2020
Nanometer-Sized Aggregates Generated Using Short Solubility Controlling Peptide Tags Do Increase the <i>In Vivo</i> Immunogenicity of a Nonimmunogenic ProteinNafsoon Rahman, Mohammad Monirul Islam, Satoru Unzai, et al.
Frontiers in Immunology|April 8, 2020
Anti-Dengue ED3 Long-Term Immune Response With T-Cell Memory Generated Using Solubility Controlling Peptide TagsMohammad M Islam, Shiho Miura, Mohammad N Hasan, et al.
Gynecologic Oncology Reports|May 6, 2026
Pathological complete response following systemic therapy with carboplatin-paclitaxel plus pembrolizumab for initially unresectable mismatch repair-deficient advanced endometrial cancer: two case reportsNanami Uetake, Shiho Miura, Yurina Suzuki, et al.
Frontiers in Immunology|June 28, 2021
Solubility Controlling Peptide Tags of Opposite Charges Generate a Bivalent Immune Response Against Dengue ED3 Serotypes 3 and 4Nafsoon Rahman, Shiho Miura, Mami Okawa, et al.
International Journal of Cancer|August 25, 2006
Do we need a different strategy for HPV screening and vaccination in East Asia?Shiho Miura, Koji Matsumoto, Akinori Oki, et al.
Organic Letters|March 27, 2013
Three-dimensional structural diversity-oriented peptidomimetics based on the cyclopropylic strainAkira Mizuno, Shiho Miura, Mizuki Watanabe, et al.
Vaccine|February 23, 2010
Oral immunization with a Lactobacillus casei vaccine expressing human papillomavirus (HPV) type 16 E7 is an effective strategy to induce mucosal cytotoxic lymphocytes against HPV16 E7Katsuyuki Adachi, Kei Kawana, Terufumi Yokoyama, et al.
Infection and Immunity|May 7, 2008
Expression of CD1d and ligand-induced cytokine production are tissue specific in mucosal epithelia of the human lower reproductive tractKei Kawana, Junko Matsumoto, Shiho Miura, et al.
The Journal of Obstetrics and Gynaecology Research|October 15, 2013
High-risk human papillomavirus correlates with recurrence after laser ablation for treatment of patients with cervical intraepithelial neoplasia 3: a long-term follow-up retrospective studyKanako Inaba, Kazunori Nagasaka, Kei Kawana, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|July 14, 2011
Characterization of gut-derived intraepithelial lymphocyte (IEL) residing in human papillomavirus (HPV)-infected intraepithelial neoplastic lesionsSatoko Kojima, Kei Kawana, Tomoyuki Fujii, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Molecular Pharmaceutics|April 2, 2020
Nanometer-Sized Aggregates Generated Using Short Solubility Controlling Peptide Tags Do Increase the <i>In Vivo</i> Immunogenicity of a Nonimmunogenic ProteinNafsoon Rahman, Mohammad Monirul Islam, Satoru Unzai, et al.
Frontiers in Immunology|April 8, 2020
Anti-Dengue ED3 Long-Term Immune Response With T-Cell Memory Generated Using Solubility Controlling Peptide TagsMohammad M Islam, Shiho Miura, Mohammad N Hasan, et al.
Gynecologic Oncology Reports|May 6, 2026
Pathological complete response following systemic therapy with carboplatin-paclitaxel plus pembrolizumab for initially unresectable mismatch repair-deficient advanced endometrial cancer: two case reportsNanami Uetake, Shiho Miura, Yurina Suzuki, et al.
Frontiers in Immunology|June 28, 2021
Solubility Controlling Peptide Tags of Opposite Charges Generate a Bivalent Immune Response Against Dengue ED3 Serotypes 3 and 4Nafsoon Rahman, Shiho Miura, Mami Okawa, et al.
International Journal of Cancer|August 25, 2006
Do we need a different strategy for HPV screening and vaccination in East Asia?Shiho Miura, Koji Matsumoto, Akinori Oki, et al.
Organic Letters|March 27, 2013
Three-dimensional structural diversity-oriented peptidomimetics based on the cyclopropylic strainAkira Mizuno, Shiho Miura, Mizuki Watanabe, et al.
Vaccine|February 23, 2010
Oral immunization with a Lactobacillus casei vaccine expressing human papillomavirus (HPV) type 16 E7 is an effective strategy to induce mucosal cytotoxic lymphocytes against HPV16 E7Katsuyuki Adachi, Kei Kawana, Terufumi Yokoyama, et al.
Infection and Immunity|May 7, 2008
Expression of CD1d and ligand-induced cytokine production are tissue specific in mucosal epithelia of the human lower reproductive tractKei Kawana, Junko Matsumoto, Shiho Miura, et al.
The Journal of Obstetrics and Gynaecology Research|October 15, 2013
High-risk human papillomavirus correlates with recurrence after laser ablation for treatment of patients with cervical intraepithelial neoplasia 3: a long-term follow-up retrospective studyKanako Inaba, Kazunori Nagasaka, Kei Kawana, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|July 14, 2011
Characterization of gut-derived intraepithelial lymphocyte (IEL) residing in human papillomavirus (HPV)-infected intraepithelial neoplastic lesionsSatoko Kojima, Kei Kawana, Tomoyuki Fujii, et al.
Pageof 2